111

Click in for more news from The Hill {beacon} Health Care   The Big Story Pill version of Wegovy could widen access The FDA just approved the first pill version of a blockbuster GLP-1 drug for weight loss, a move that could significantly widen access to the treatment, though the full costs aren't c…
219

It’s the liver – not the skin – that rids the body of the toxins in alcohol, but exercise can help manage the symptomsHere’s a useful fact to quote to any smug relatives who say they went for a run the morning after their Christmas party: you can’t get rid of toxins by sweating. “Toxins” is a broad …
111

The Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's blockbuster weight-loss drug Wegovy that the company said will be available early in the new year. Why it matters: It's the first oral GLP-1 drug approved for weight loss and could provide a more convenient an…
431

A new study involving the Medical University of Vienna shows how the multi-resistant fungus Candida auris utilizes carbon dioxide (CO₂) to survive on the skin and become resistant to antifungal therapies. The research team identified several new targets that could be used in the future to curb the s…